Healing the body and soul: Traditional remedies for "magical" ailments, nervous system and psychosomatic disorders in Northern Peru

African Journal of Pharmacy and Pharmacology

Volumn 4, Issue 9, 2010, Pages 580-629

  Bussmann, Rainer W ^a   Glenn, Ashley ^a   Sharon, Douglas ^b  

^a MISSOURI BOTANICAL GARDEN   (United States)

^b NONE   (United States)

Author keywords

Etheogens; Ethnobotany; Medicinal plants; Mental health; Neurologic disorders; Psychopharmacology

Indexed keywords

HERBACEOUS AGENT;

AMNESIA; ANGIOSPERM; ARTICLE; ASTERACEAE; HERBAL MEDICINE; HUMAN; HYPERICUM; NEUROLOGIC DISEASE; NEUROTOXICITY; PERU; PSYCHOSOMATIC DISORDER; SCUTELLARIA BAICALENSIS; SPECIES IDENTIFICATION; TRADITIONAL MEDICINE;

EID: 78649827215     PISSN: None     EISSN: 19960816     Source Type: Journal    
DOI: None     Document Type: Article

References (237)

1. Acosta J de (1590). Historia natural y moral de las Indias. Sevilla.
2. Aguirre-Hernández E, Martínez AL, González-Trujano ME, Moreno J, Vibrans H, Soto-Hernández M (2007a). Pharmacological evaluation of the anxiolytic and sedative effects of Tilia americana L. var. mexicana in mice. J. Ethnopharmacol., 109(1): 140-175.
3. Aguirre-Hernández E, Rosas-Acevedo H, Soto-Hernández M, Martínez AL, Moreno J, González-Trujano ME (2007b). Bioactivity-guided isolation of beta-sitosterol and some fatty acids as active compounds in the anxiolytic and sedative effects of Tilia americana var. mexicana. Planta Medica, 73(11): 1148-1155.
4. Alarco de Zandra A (1988). Perú, el libro de las plantas mágicas. Concytec, Lima, p. 152. Alcedo A de (1786-89). Diccionario geografico histórico de las indias occidentales o América. Madrid.
5. Alcedo A de (1786-89). Diccionario geografico histórico de las indias occidentales o América. Madrid.
6. Al-Said MS, Tariq M, al-Yahya MA, Rafatullah S, Ginnawi OT, Ageel AM (1990). Studies on Ruta chalepensis, an ancient medicinal herb still used in traditional medicine. J. Ethnopharmacol., 28(3): 305-312.
7. Amos S, Chindo BA, Abbah J, Vongtau HO, Edmond I, Binda L, Akah PA, Wambebe C, Gamaniel KS (2003). Postsynaptic dopamine (D(2))-mediated behavioural effects of high acute doses of artemisinin in rodents. Brain Res. Bull., 62(3): 255-260.
8. Autore G, Capasso F, De Feo V, De Simone F, Mascolo N (1994). Attività gastrointestinale di Huperzia sp. (Lycopodiaceae). Atti del IV Congresso Italo-Latinoamericano di Etnomedicina, Roma, 19-22 settembre 1994, p. 33.
9. Avallone R, Zanoli P, Puia G, Kleinschnitz M, Schreier P, Baraldi M (2000). Pharmacological profile of apigenin, a flavonoid isolated from Matricaria chamomilla. Biochem. Pharmacol., 59(11): 1387-1394.
10. Awad R, Levac D, Cybulska P, Merali Z, Trudeau VL, Arnason JT (2007). Effects of traditionally used anxiolytic botanicals on enzymes of the gamma-aminobutyric acid (GABA) system. Can. J. Physiol. Pharmacol., 85(9): 933-942.
11. Azaizeh H, Saad B, Khalil K, Said O (2006). The State of the Art of Traditional Arab Herbal Medicine in the Eastern Region of the Mediterranean: A Review. Evidence Based Complementary Alternative Med., 3(2): 229-235.
12. Barbosa NR, Pittella F, Gattaz WF (2008). Centella asiatica water extract inhibits iPLA2 and cPLA2 activities in rat cerebellum. Phytomedicine, 15(10): 896-900.
13. Barreiro Arcos ML, Cremaschi G, Werner S, Coussio J, Ferraro G, Anesini C (2006). Tilia cordata Mill. Extracts and scopoletin (isolated compound), differential cell growth effects on lymphocytes. Phytotherapr Res., 20(1): 34-40.
14. Béjar E, Bussmann RW, Roa C, Sharon D (2001). Herbs of Southern Ecuador - Hierbas del Sur Ecuatoriano. Latin Herbal Press, San Diego.
15. Béjar E, Bussmann RW, Roa C, Sharon D (1997). Pharmacological search for active ingredients in medicinal plants of Latin America. In: Shuman T, Garrett M, Wozniak L (eds) International Symposium on Herbal Medicine, A Holistic Approach. SDSU International Institute for Human Resources Development, San Diego, pp. 63-81.
16. Berenguer J (1987). Consumo nasal de alucinogenos en Tiwanaku, una aproximacidn iconogrifica. Boletin del Museo Chileno de Arte Precolombino, 2: 33-53.
17. Bhattacharya S, Pal S, Chaudhuri AK (1988). Neuropharmacological studies on Mikania cordata root extract. Planta Medica., 54(6): 483-487.
18. Bhattacharya D, Jana U, Debnath PK, Sur TK (2007). Initial exploratory observational pharmacology of Valeriana wallichii on stress management, a clinical report. Nepal Med. College J., 9(1): 36-39.
19. Bianchi A, Samorini G (1993). Plants in association with ayahuasca. Jahrbuch für Etnomedizin: pp. 21-42.
20. Block KI, Gyllenhaal C, Mead MN (2004). Safety and efficacy of herbal sedatives in cancer care. Integrative Cancer Ther., 3(2): 128-148.
21. Bonavia D, Ochoa CM, Tovar SO, Cerrón Palomino R (2004). Archaeological evidence of Cherimoya (Annona cherimola Mill.) and Guanabana (Annona muricata L.) in ancient Peru. Econ. Bot., 58(4): 509-522.
22. Bradwejn J, Zhou Y, Koszycki D, Shlik J (2000). A double-blind, placebo-controlled study on the effects of Gotu Kola (Centella asiatica) on acoustic startle response in healthy subjects. J. Clin. Psychopharmacol., 20(6): 680-684.
23. Brako L, Zarucchi JL (1993). Catalogue of the Flowering Plants and Gymnosperms of Peru. Missouri Botanical Garden, Saint Louis, MO.
24. Breevort P (1998). The Booming U.S. Botanical Market, A New Overview. HerbalGram 44: 33-46.
25. Bristol ML (1969). Tree Datura drugs of the Colombian Sibundoy. Botanical Museum Leaflets, Harvard University, 22: 165-227.
26. Bruhn JG, De Smet PA, El-Seedi HR, Beck O (2002). Mescaline use for 5,700 years. Lancet 359: 1866.
27. Buletsa BA (1969). On the facial reflexes of patients with diseases of the nervous system. Zh Nevropatol Psikhiatr Im S S Korsakova 69(5): 689-92.
28. Bussmann RW, Sharon D, Lopez A (2007). Blending Traditional and Western Medicine, Medicinal plant use among patients at Clinica Anticona in El Porvenir, Peru. Ethnobot. Res. Appl., 5: 185-199.
29. Bussmann RW, Sharon D (2007). Plants of the four winds - The magic and medicinal flora of Peru. Plantas de los cuatro vientos - La flora mágica y medicinal del Perú. Graficart, Trujillo.
30. Bussmann RW (2002). Ethnobotany and Biodiversity Conservation. In Ambasht RS, Ambasht NK (eds) Modern Trends in Applied Terrestrial Ecology, Kluwer, New York, pp. 345-362.
31. Bussmann RW (2006). Manteniendo el balance de naturaleza y hombre, La diversidad florística andina y su importancia por la diversidad cultural - ejemplos del Norte de Perú y Sur de Ecuador. Arnaldoa 13(2): 382-397.
32. Bussmann RW, Sharon D (2006). Traditional plant use in Northern Peru, Tracking two thousand years of health culture. J. Ethnobiol. Ethnomed. 2: 47.
33. Anaya Reyes-Gavilan H, Tacoronte Morales JE, Nogueiras LC, Fuentes FV, Basterrechea Rey M (1999). Determination of main alkaloids present in species of the Brugmansia section, gen. Datura Rev CENIC, Ciencia Quimica 30: 90-91.
34. Cabieses Molina F (1993). Apuntes de medicina tradicional, Vols. 1 and 2. Diselpesa, Lima.
35. Cabieses Molina F (1990). The Magic Plants of Ancient Peru. Atti del V Congresso Nazionale della Società Italiana di Fitochimica, Ischia.
36. Camino L (1992). Cerros, plantas y lagunas poderosas, la medicina al norte de Perú. Lima, Lluvia Editores.
37. Capasso A, De Feo V (2002). Central nervous system pharmacological effects of plants from northern Peruvian Andes, Valeriana adscendens, Iresine herbstii and Brugmansia arborea. Pharmaceut. Biol. 40: 274-293.
38. Capasso A, De Feo V (2003). Alkaloids from Brugmansia arborea (L.) Lagerheim reduce morphine withdrawal in vitro. Phytother. Res. 17(7): 826-829.
39. Capasso A, De Feo V, De Simone F, Sorrentino L (1996). Pharmacological effects of aqueous extract from Valeriana adscendens. Phytother. Res. 10: 309-312.
40. Capasso A, De Feo V, De Simone F, Sorrentino L (1997). Activitydirected isolation of spasmolytic (anti-cholinergic) alkaloids from Brugmansia arborea (L.) Lagerheim. Intl. J. Pharmacog. 35: 43-48.
41. Capasso A, Di Giannuario A, Loizzo A, Pieretti S, Sagratella S, Sorrentino L (1996). Dexamethasone selective inhibition of acute opioid physical dependence in isolated tissues. J. Pharmacol. Exper. Ther. 276: 743-751.
42. Capasso A, Di Giannuario A, Loizzo A, Pieretti S, Sorrentino L (1991a). Dexamethasone induced biphasic effects on morphine hypermotility in mice. Life Sci. 49: 1411-1418.
43. Capasso A, Di Giannuario A, Loizzo A, Pieretti S, Sorrentino L (1992). Central interaction of dexamethasone and RU-38486 on morphine antinociception in mice. Life Sci. 52: 139-143.
44. Capasso A, Pinto A, Mascolo N, Autore G, Capasso F (1991b). Reduction of agonist-induced contractions of guineapig isolated ileum by flavonoids. Phytother. Res. 5: 85-87.
45. Capasso R, Borrelli F, Capasso F, Siebert DJ, Stewart DJ, Zjawiony JK, Izzo AA (2006). The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A inhibit enteric cholinergic transmission in the guinea-pig ileum. Neurogastroenterol Motil. 18(1): 69-75.
46. Carlini EA (2003). Plants and the central nervous system. Pharmacol. Biochem. Behav. 75(3): 501-512.
47. Catalano S, Cioni PL, Menichini A, Bilia AR, Morelli I, De Feo V (1993). Kauranoid diterpenes in Gynoxys oleifolia. Planta Med. 59: 278-280.
48. Cavadas C, Araujo I, Cotrim MD, Amaral T, Cunha AP, Macedo T, Ribeiro CF (1995). In vitro study on the interaction of Valeriana officinalis L. extracts and theiramino acids on the GABA receptor in rat brain. Arzneimittelforschung 45: 753-755.
49. Chandhoke N, Ghatak BJ (1969). Studies on Tagetes minuta, some pharmacological actions of the essential oil. Indian J. Med. Res. 57(5): 864-876.
50. Chiappe M, Lemlij M, Millones L (1985). Alucinogenos y Shamanismo en el Peru contemporaneo. El Virrey, Lima.
51. Choochote W, Tuetun B, Kanjanapothi D, Rattanachanpichai E, Chaithong U, Chaiwong P, Jitpakdi A (2004). Potential of crude seed extract of celery, Apium graveolens L., against the mosquito Aedes aegypti (L.) (Diptera, Culicidae). J. Vector Ecol. 29(2): 340-346.
52. Classen W, Altmann B, Gretener P, Souppart C, Skelton-Stroud P, Krinke G (1999). Differential effects of orally versus parenterally administered qinghaosu derivative artemether in dogs. Exper. Toxicol. Pathol. 51(6): 507-516.
53. Cobo B (1653). Historia del Nuevo Mundo, 2 tomos. Sevilla.
54. Cobo B (1956). In: de Mateos, F., (ed) Historia del Nuevo Mundo. Ediciones Atlas, Madrid.
55. Coleta M, Campos MG, Cotrim MD, Proença da Cunha A (2001). Comparative evaluation of Melissa officinalis L., Tilia europaea L., Passiflora edulis Sims. and Hypericum perforatum L. in the elevated plus maze anxiety test. Pharmacopsychiatry 34(1): 20-21.
56. Corral I, Martín-Dávila P, Fortún J, Navas E, Centella T, Moya JL, Cobo J, Quereda C, Pintado V, Morenok S (2007). Trends in neurological complications of endocarditis. J. Neurol. 254(9): 1253-1259.
57. Cosola C, Albrizio M, Guaricci AC, De Salvia MA, Zarrilli A, Sciorsci RL, Minoia R (2006). Opioid agonist/antagonist effect of naloxone in modulating rabbit jejunum contractility in vitro. J. Physiol. Pharmacol. 57(3): 439-449.
58. Crosby DM, McLaughlin JL (1973). Cactus alkaloids. XIX. Crystallization of mescaline HCl and 3-methoxytyramine HCl from Trichocerues pachanoi. Lloydia 36: 416-418.
59. Cruz Sánchez G (1948). Informe sobre las aplicaciones populares de la cimora en el norte del Perú. Revista de Farmacol. y Med. Exper., Lima 1: 253-258.
60. Da Silveira DX, Grob CS, de Rios MD, Lopez E, Alonso LK, Tacla C, Doering-Silveira E (2005). Ayahuasca in adole-scence, a preliminary psychiatric assessment. J. Psychoact. Drugs, 37(2): 129-33.
61. Davis EW (1983). Sacred plants in the San Pedro cult. Botanical Museum Leaflets, Harvard University 29: 367-382.
62. De Feo V, Faro C (2002). Pharmacological effects of extracts from Valeriana adscendens Trel. II. Effects on GABA uptake and amino acids. Phytother. Res., 17(6): 661-664.
63. De Feo V (2003). Ethnomedicinal field study in northern Peruvian Andes with particular reference to divination practices. J. Ethnopharmacol., 85: 243-256.
64. De Feo V (1992). Medicinal and magical plants on northern Peruvian Andes. Fitoterapia, 63: 417-440.
65. De Feo V, Capasso A, De Simone F, Sorrentino L (1996). CNS pharmacological effects of aqueous extract from Iresine herbstii. Intl. J. Pharmacog., 34: 184-188.
66. De Feo V, della Valle C, De Simone F, Pizza C (1992). Chemical constituents and antimicrobial activity of Arcytophyllum nitidum HBK. Annal. Chim., 82: 476-486.
67. de Lima TC, Morato GS, Takahashi RN (1993). Evaluation of the central properties of Artemisia verlotorum. Planta Med., 59(4): 326-329.
68. De Smet PAGM (1985). A multidisciplinary overview of intoxicating snuff rituals in the western hemisphere. J. Ethnopharmacol., 13: 3-49.
69. Demetriades AK, Wallman PD, McGuiness A, Gavalas MC (2005). Low cost, high risk, accidental nutmeg intoxication. Emerg. Med. J., 22(3): 223-225.
70. Dianova RG (1960). Effect of platyphylline on the activity of certain substances depressing the central nervous system. Farmakol. Toksikol., 23: 106-9.
71. Dobkin de Rios M (1968). Trichocereus pachanoi, a mescaline cactus used in folk healing uses in Peru. Econ. Bot., 22: 191-194.
72. Dobkin de Rios M (1969). Folk curing with a psychedelic cactus in North Coast Peru. Intl. J. Soc. Psych., 15: 23-32.
73. Dobkin de Rios M (1977). Plant hallucinogens and the religion of the Mochica, an ancient Peruvian people. Econ. Bot., 31: 189-203.
74. Dobkin de Rios M, Cardenas M (1980). Plant hallucinogen, shamanism and Nazca ceramics. J. Ethnopharmacol., 2: 233-246.
75. Dunaev VV, Trzhetsinskii SD, Tishkin VS, Fursa NS, Linenko VI (1987). Biological activity of the sum of valepotriates isolated from Valeriana alliariifolia. Farmakol. Toksikol. 50: 33-37.
76. Elferink JG (1983). The narcotic and hallucinogenic use of tobacco in pre-Columbian Central America. J. Ethnopharmacol., 7: 111-122.
77. Emamghoreishi M, Khasaki M, Aazam MF (2005). Coriandrum sativum, evaluation of its anxiolytic effect in the elevated plus-maze. J. Ethnopharmacol., 96(3): 365-370.
78. Ernst E (2006). Herbal remedies for anxiety - a systematic review of controlled clinical trials. Phytomedicine, 13(3): 205-208.
79. EsSalud/Organización Panamericana de Salud (2000). Estudio Costo-Efectividad: Programa Nacional de Medicina Complementaria. Seguro Social de EsSalud (Study of Cost-Effectiveness: National Program in Complementary Medicine. Social Security of EsSalud). Lima, EsSalud/Organización Panamericana de Salud (Pan American Health Organization).
80. Evans WC (1979). Tropane alkaloids of the Solanaceae. In: Hawkes JG, Lester RN, Shelding AD (eds) The Biology and Taxonomy of Solanaceae. Linnean Society Symposia Series no. 7. Academic Press, London, pp. 245-254.
81. Fachinetto R, Villarinho JG, Wagner C, Pereira RP, Avila DS, Burger ME, Calixto JB, Rocha JB, Ferreira J (2007). Valeriana officinalis does not alter the orofacial dyskinesia induced by haloperidol in rats, role of dopamine transporter. Progress in Neuropsychopharmacol. Biol. Psych. 31(7): 1478-1486.
82. Fejes S, Kéry A, Blázovics A, Lugasi A, Lemberkovics E, Petri G, Szöke E (1998). Investigation of the in vitro antioxidant effect of Petroselinum crispum (Mill.) Nym. ex A. W. Hill. Acta Pharmacologica Hungarica, 68(3): 150-6.
83. Fernández Honores AM, Rodrígues Rodríguez EF (2007). Etnobotánica del Perú pre-hispáno. Universidad Nacional Trujillo, Peru.
84. Franco CI, Morais LC, Quintans-Júnior LJ, Almeida RN, Antoniolli AR (2005). CNS pharmacological effects of the hydroalcoholic extract of Sida cordifolia L. leaves. J. Ethnopharmacol., 98(3): 275-279.
85. Freire CM, Marques MO, Cost M (2006). Effects of seasonal variation on the central nervous system activity of Ocimum gratissimum L. essential oil. J. Ethnopharmacol., 105(1-2): 161-166.
86. Frison G, Favretto D, Zancanaro F, Fazzin G, Ferrara SD (2008). A case of beta-carboline alkaloid intoxication following ingestion of Peganum harmala seed extract. Fore. Sci. Intl. 179(2-3): 37-43.
87. Gaitonde BB, Joglekar SN (1977). Mechanism of neurotoxicity of cardiotonic glycosides. Br. J. Pharmacol., 59(2): 223-229.
88. Gambaro VE, Roses OE (1989). La presencia de nicotina en extractos y decocciones de flores de Brugmansia candida Pers. Acta Farm Bonaerense, 8: 17-22.
89. Geller SE, Studee L (2007). Botanical and dietary supplements for mood and anxiety in menopausal women. Menopause. 14(3 Pt 1): 541-549.
90. Gennaro MC, Gioannini E, Giacosa D, Siccardi D (1996). Determination of mescaline in hallucinogenic Cactaceae by ion-interaction HPLC. Anal. Lett., 29: 2399-2409.
91. Gharzouli K, Khennouf S, Amira S, Gharzouli A (1999). Effects of aqueous extracts from Quercus ilex L. root bark, Punica granatum L. fruit peel and Artemisia herba-alba Asso leaves on ethanol-induced gastric damage in rats. Phytother. Res., 13(1): 42-45.
92. Glass-Coffin B, Sharon D, Uceda S (2004). Curanderos a la sombra de la Huaca de la luna. Bulletin Institute francaise Etudes andines 33(1): 81-95.
93. Griffin WJ, Lin DG (2000). Chemotaxonomy and geographical distribution of tropane alkaloids. Phytochemistry, 53: 623-637.
94. Guadarrama-Cruz G, Alarcon-Aguilar FJ, Lezama-Velasco R, Vazquez-Palacios G, Bonilla-Jaime H (2008). Antidepressant-like effects of Tagetes lucida Cav. in the forced swimming test. J. Ethnopharmacol. 120(2): 277-281.
95. Hammond GB, Fernández ID, Villegas L, Vaisbeerg AJ (1998). Survey of traditional medicinal plants from the Callejón de Huaylas, Department of Ancash, Perú. J. Ethnopharmacol. 61: 17-30.
96. Hattesohl M, Feistel B, Sievers H, Lehnfeld R, Hegger M, Winterhoff H (2008). Extracts of Valeriana officinalis L. s.l. show anxiolytic and antidepressant effects but neither sedative nor myorelaxant properties. Phytomedicine 15(1-2): 2-15.
97. Haze S, Sakai K, Gozu Y (2002). Effects of fragrance inhalation on sympathetic activity in normal adults. Japanese. J. Pharmacol., 90(3): 247-253.
98. Hellión-Ibarrola MC, Ibarrola DA, Montalbetti Y, Kennedy ML, Heinichen O, Campuzano M, Tortoriello J, Fernández S, Wasowski C, Marder M, De Lima TC, Mora S (2006). The anxiolytic-like effects of Aloysia polystachya (Griseb.) Moldenke (Verbenaceae) in mice. J. Ethnopharmacol. 105(3): 400-408.
99. Henderson L, Yue QY, Bergquist C, Gerden B, Arlett P (2002). St John's wort (Hypericum perforatum), drug interactions and clinical outcomes. Br. J. Clin. Pharmacol., 54(4): 349-356.
100. Herrera-Ruiz M, García-Beltrán Y, Mora S, Díaz-Véliz G, Viana GS, Tortoriello J, Ramírez G (2006). Antidepressant and anxiolytic effects of hydroalcoholic extract from Salvia elegans. J. Ethnopharmacol., 107(1): 53-58.
101. Herrera-Ruiz M, Román-Ramos R, Zamilpa A, Tortoriello J, Jiménez-Ferrer JE (2008). Flavonoids from Tilia americana with anxiolytic activity in plus-maze test. J. Ethnopharmacol., 118(2): 312-317.
102. Ho NK (1996). Traditional Chinese medicine and treatment of neonatal jaundice. Singapore Med. J., 37(6): 645-651.
103. Hocquenghem AM (1987). Iconografía Mochica. Fondo Editorial de la Pontificia Universidad Católica del Perú, Lima.
104. Houghton PJ (1999). The scientific basis for the reputed activity of Huang L, Abuhamdah S, Howes MJ, Elliot MS, Ballard C, Holmes C, Burns A, Perry EK, Francis PT, Lees G, Chazot PL (2008). Pharmacological profile of essential oils derived from Lavandula angustifolia and Melissa officinalis with anti-agitation properties, focus on ligand-gated channels. J. Pharm. Pharmacol. 60(11): 1515-1522.
105. Imanshahidi M, Hosseinzadeh H (2006). The pharmacological effects of Salvia species on the central nervous system. Phytother. Res. 20(6): 427-437.
106. Imura M, Misao H, Ushijima H (2006). The psychological effects of aromatherapy-massage in healthy postpartum mothers. J. Midwifery Womens Health 51(2): 1-7.
107. Interaminense LF, Leal-Cardoso JH, Magalhães PJ, Duarte GP, Lahlou S (2005). Enhanced hypotensive effects of the essential oil of Ocimum gratissimum leaves and its main constituent, eugenol, in DOCA-salt hypertensive conscious rats. Planta Med. 71(4): 376-378.
108. Janiger O, Dobkin de Rios M (1976). Nicotiana, an hallucinogen? Econ. Bot. 30: 149-151.
109. Joralemon D, Sharon D (1993). Sorcery and Shamanism, Curanderos and Clients in Northern Peru. University of Utah Press, Salt Lake City.
110. Jørgensen PM, León-Yanez S (1999). Catalogue of the vascular plants of Ecuador. - Monographs in Systematic Botany from the Missouri Botanical Garden p. 75.
111. Jørgensen PM, Ulloa Ulloa C (1994). Seed plants of the High Andes of Ecuador - a Checklist. AAU Reports 34: 1-443.
112. Kasper S, Anghelescu I-G, Szegedi A, Dienel A, Kieser M (2006). Superior efficacy of St. John's Wort extract WS® 5570 compared to placebo in patients with major depression, a randomized, doubleblind, placebo-controlled, multi-center trial [ISRCTN77277298] BMC Med. 4: 14.
113. Kawamoto R, Murase C, Ishihara I, Ikushima M, Nakatani J, Haraga M, Shimizu J (2005). The effect of lemon fragrance on simple mental performance and psychophysiological parameters during task performance. J. UOEH. 27(4): 305-313.
114. Kim DH, Jeon SJ, Son KH, Jung JW, Lee S, Yoon BH, Lee JJ, Cho YW, Cheong JH, Ko KH, Ryu JH (2007). The ameliorating effect of oroxylin A on scopolamine-induced memory impairment in mice. Neurobiol. Learning Memoirs 87(4): 536-546.
115. Kim JM, Choi SM, Kim DH, Oh TY, Ahn BO, Kwon JW, Kim WB (2005). Combined use of omeprazole and a novel antioxidative cytoprotectant for the treatment of peptic ulcer. Facilitation of ulcer healing in experimental animals. Arzneimittelforschung. 55(7): 387-393.
116. Klüver H (1966). Mescal and Mechanisms of Hallucinations. Phoenix Books. The University of Chicago Press, Chicago, pp. 65-80.
117. Knauer LA, Maloney WJ (1913). A preliminary note on the psychic action of mescaline with special reference to the mechanism of visual hallucinations. J. Nerv. Mental Disord. 40: 425-436.
118. Kohli RP, Dua PR, Shanker K, Saxena RC (1967). Some central effects of an essential oil of Apium graveolens (Linn.). Indian J. Med. Res. 55(10): 1099-1102.
119. Komiya M, Takeuchi T, Harada E (2006). Lemon oil vapor causes an anti-stress effect via modulating the 5-HT and DA activities in mice. Behav. Brain Res. 172(2): 240-249.
120. Kovar KA (1998). Chemistry and pharmacology of hallucinogens, entactogens and stimulants. Pharmacopsychiatry 31(2): 69-72.
121. Krystal AD (2007). Treating the health, quality of life, and functional impairments in insomnia. J. Clin. Sleep Med. 3(1): 63-72.
122. Kulshrestha VK, Singh N, Saxena RC, Kohli RP (1970). A study of central pharmacological activity of alkaloid fraction of Apium graveolens Linn. Indian J. Med. Res. 58(1): 9-102.
123. Lahlou S, Interaminense L de F, Leal-Cardoso JH, Morais SM, Duarte GP (2004). Cardiovascular effects of the essential oil of Ocimum gratissimum leaves in rats, role of the autonomic nervous system. Clin. Exper. Pharmacol. Physiol. 31(4): 219-225.
124. Larco Hoyle R (1948). Cronología Arqueológica del Norte del Perú. Buenos Aires.
125. Larco Hoyle R (2001). Los Mochicas (I and II.) Museo Arqueológico Rafael Larco Herrerra, Lima.
126. Leathwood PD, Chauffard F (1985). Aqueous extract of valerian reduces latency to fall asleep in man. Plant. Med. 51: 144-147.
127. Leathwood PD, Chauffard F, Heck E, Munoz-Box R (1982). Aqueous extract of valerian (Valeriana officinalis) improves sleep quality in man. Pharmacol. Biochem. Behavior., 17: 65-72.
128. Lehrner J, Marwinski G, Lehr S, Johren P, Deecke L (2005). Ambient odors of orange and lavender reduce anxiety and improve mood in a dental office. Physiol. Behav., 86(1-2): 92-95.
129. Leuschner J, Müller J, Rudmann M (1993). Characterization of central nervous depressant activity of commercially available valerian root extract. Arzneimittelforschung, 43: 638-641.
130. Lim BO, Chung HG, Lee WH, Lee HW, Suk K (2008). Inhibition of microglial neurotoxicity by ethanol extract of Artemisia asiatica Nakai. Phytother. Res., 22(2): 279-282.
131. Lockwood TE (1979). The ethnobotany of Brugmansia. J. Ethnopharmacol., 1: 147-164.
132. López TA, Campero CM, Chayer R, de Hoyos M (1997). Ergotism and photosensitization in swine produced by the combined ingestion of Claviceps purpurea sclerotia and Ammi majus seeds. J. Vet Diagn. Invest., 9(1): 68-71.
133. Marin RH, Garcia DA, Martijena ID, Zygadlo JA, Arce A, Perillo MA (1998). Anxiogenic-like effects of Tagetes minuta L essential oil on Tmaze and tonic immobility behaviour in domestic chicks. Fundamentals Clin. Pharmacol., 12(4): 426-432.
134. Martínez Compañon DB (1789). Razon de las especies de la naturaleza y del arte del obispado de Trujillo del Perú. Vol. III-V.
135. Marles RJ (1988). Ethnopharmacology of the lowland Quichua of Eastern Ecuador. Ph.D. dissertation, University of Illinois at Chicago.
136. Martin RT (1970). The role of coca in the history, religion, and medicine of South American Indians. Econ. Bot., 24: 422-438.
137. McBride JF (ed) (1938-1981). Flora of Peru. Fieldiana, Botany. Field Museum of Natural History, Chicago.
138. McClelland D (1977). The Ulluchu - A Moche Symbolic Fruit. In: Cordy- Collins A, Stern J (eds) Pre-Columbian Art History. Peek Publications, Palo Alto, pp.435-452.
139. McKenna DJ, Towers GHN, Abbott F (1984). Monoamine oxidase inhibitors in South American hallucinogenic plants, tryptamine and beta-carboline constituents of ayahuasca. J. Ethnopharmacol., 10: 195-223.
140. McKenna DJ, Luna LE, Towers CHN (1986). Ingredientes biodinamicos en las plantas que se mezclan al ayahuasca. Una farmacopea tradicional no identificada. Am. Indig., 46: 73-98.
141. Miyasaka LS, Atallah AN, Soares BG (2006). Valerian for anxiety disorders. Cochrane Database Syst. Rev.
142. Molina-Hernandez M, Tellez-Alcantara NP, Diaz MA, Perez Garcia J, Olivera Lopez JI, Jaramillo MT (2004). Anticonflict actions of aqueous extracts of flowers of Achillea millefolium L. vary according to the estrous cycle phases in Wistar rats. Phytother. Res., 18(11): 915-920.
143. Monardes N (1574). Primera y segunda y tercera partes de la história medicinal de las cosas que se traen de nuestras Indias Occidentales, que sirven en medicina; Tratado de la piedra bezaar, y dela yerva escuerçonera; Diálogo de las grandezas del hierro, y de sus virtudes medicinales; Tratado de la nieve, y del beuer frio. Sevilla, Alonso Escribano.
144. Mora S, Díaz-Véliz G, Millán R, Lungenstrass H, Quirós S, Coto-Morales T, Hellión-Ibarrola MC (2005). Anxiolytic and antidepressantlike effects of the hydroalcoholic extract from Aloysia polystachya in rats. Pharmacol. Biochem. Behavior., 82(2): 373-378.
145. Mora S, Millán R, Lungenstrass H, Díaz-Véliz G, Morán JA, Herrera-Ruiz M, Tortoriello J (2006). The hydroalcoholic extract of Salvia elegans induces anxiolytic- and antidepressant-like effects in rats. J. Ethnopharmacol., 106(1): 76-81.
146. Morgan AJ, Jorm AF (2008). Self-help interventions for depressive disorders and depressive symptoms, a systematic review. Ann. Gen. Psych., 7: 13.
147. Naranjo P (1981). Social function of coca in pre-Columbian America. J. Ethnopharmacol., 3: 161-172.
148. Newsholme SJ, Kellerman TS, Welman WG (1984). Pathology of a nervous disorder (pushing disease or "stootsiekte") in cattle caused by the plant Matricaria nigellifolia DC. (Asteraceae). Onderstepoort J. Vet. Res., 51(2): 119-127.
149. Nogueira E, Rosa GJ, Haraguchi M, Vassilieff VS (1998a). Anxiolytic effect of Rubus brasilensis in rats and mice. J. Ethnopharmacol., 61(2): 111-117.
150. Nogueira E, Rosa GJ, Vassilieff VS (1998b). Involvement of GABA(A)- benzodiazepine receptor in the anxiolytic effect induced by hexanic fraction of Rubus brasiliensis. J. Ethnopharmacol., 61(2): 119-126.
151. O'Connor KA, Roth BL (2005). Screening the receptorome for plantbased psychoactive compounds. Life Sci., 78(5): 506-511.
152. Oh TY, Ahn GJ, Choi SM, Ahn BO, Kim WB (2005). Increased susceptibility of ethanol-treated gastric mucosa to naproxen and its inhibition by DA-9601, an Artemisia asiatica extract. World J. Gastroenterol., 11(47): 7450-7456.
153. Okuyama E, Okamoto Y, Yamazaki M, Satake M (1996). Pharmacologically active components of a Peruvian medicinal plant, huanarpo (Jatropha cilliata). Chem. Pharmacol. Bull. (Tokyo), 44(2): 333-336.
154. Ortiz JG, Nieves-Natal J, Chavez P (1999). Effects of Valeriana officinalis extracts on [3H]flunitrazepam binding, synaptosomal [3H]GABA uptake, and hippocampal [3H]GABArelease. Neurochem. Res., 24: 1373-1378.
155. Pardanani JH, McLaughlin JL, Kondrat RW, Cooks RG (1977). Cactus alkaloids. XXXVI. Mescaline and related compounds from Trichocereus peruvianus. Lloydia, 40: 585-590.
156. Park HG, Yoon SY, Choi JY, Lee GS, Choi JH, Shin CY, Son KH, Lee YS, Kim WK, Ryu JH, Ko KH, Cheong JH (2007). Anticonvulsant effect of wogonin isolated from Scutellaria baicalensis. Eur. J. Pharmacol., 574(2-3): 112-119.
157. Perazzo FF, Carvalho JC, Carvalho JE, Rehder VL (2003). Central properties of the essential oil and the crude ethanol extract from aerial parts of Artemisia annua L. Pharmacol. Res., 48(5): 497-502.
158. Pereira P, Tysca D, Oliveira P, da Silva Brum LF, Picada JN, Ardenghi P (2005). Neurobehavioral and genotoxic aspects of rosmarinic acid. Pharmacol. Res., 52(3): 199-203.
159. Pérez-Ortega G, Guevara-Fefer P, Chávez M, Herrera J, Martínez A, Martínez AL, González-Trujano ME (2008). Sedative and anxiolytic efficacy of Tilia americana var. mexicana inflorescences used traditionally by communities of State of Michoacan, Mexico. J. Ethnopharmacol., 116(3): 461-468.
160. Pestalozzi HU (1998). Flora ilustrada altoandina. Herbario Nacional de Bolivia and Herbario Forestal Nacional Martín Cardenas, Cochabamba.
161. Plotkin MJ, Mittermeier RA, Costable I (1980). Psychotomimetic use of tobacco in Surinam and French Guiana. J. Ethnopharmacol., 2: 295-297.
162. Plowman T (1977). Brunfelsia in ethnomedicine. Botanical Musaum Leaflets 25: 289-320.
163. Plowman T (1981). Amazonian coca. J. Ethnopharmacol., 3: 195-225.
164. Plowman T (1984a). The ethnobotany of coca (Erythroxylum spp., Erythroxylaceae). Advances Econ. Bot., 1: 62-111.
165. Plowman T (1984b). The origin, evolution, and diffusion of coca, Erythroxylum spp., in South and Central America. Papers Peabody Museum Archaeol. Ethnol., 76: 125-163.
166. Poindexter EH, Carpenter RD (1962). Isolation of harmane and norharmane from cigarette smoke. Chem. Ind., 26(1): 176.
167. Poisson J (1960). The presence of mescaline in a Peruvian cactus. Annales Farmaceutiques Françaises 18: 764-765.
168. Polia M (1988). Las Lagunas de los Encantos. Medicina Tradicional Andina en el Peru septentrional. Club Grau, Ce.Pe.Cer., Lima.
169. Ponnusamy K, Mohan M, Nagaraja HS (2008). Protective antioxidant effect of Centella asiatica bioflavonoids on lead acetate induced neurotoxicity. Med. J. Malaysia, 63(A): 102.
170. Prakash P, Gupta N (2005). Therapeutic uses of Ocimum sanctum Linn (Tulsi) with a note on eugenol and its pharmacological actions, a short review. Indian J. Physiol. Pharmacol., 49(2): 125-131.
171. Pultrini Ade M, Galindo LA, Costa M (2006). Effects of the essential oil from Citrus aurantium L. in experimental anxiety models in mice. Life Sci., 78(15): 1720-1725.
172. Pummangura S, McLaughlin JL, Schiffendecker RC (1982). Cactus alkaloids. LI. Lack of mescaline traslocation in grafted Trichocereus. J. Nat. Prod., 45: 215-216.
173. Ravindran R, Rathinasamy SD, Samson J, Senthilvelan M (2005). Noise-stress-induced brain neurotransmitter changes and the effect of Ocimum sanctum (Linn) treatment in albino rats. J. Pharmacol. Sci., 98(4): 354-60.
174. Riba J, Anderer P, Morte A, Urbano G, Jané F, Saletu B, Barbanoj MJ (2002). Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers. Br. J. Clin. Pharmacol., 53(6): 613-628.
175. Riba J, Valle M, Urbano G, Yritia M, Morte A, Barbanoj MJ (2003). Human pharmacology of ayahuasca, subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics. J. Pharmacol. Exper. Ther., 306(1): 73-83.
176. Rivier L, Lindgren JE (1972). Ayahuasca, the South American Hallucinogenic drink, an ethnobotanical and chemical investigation. Econ. Bot., 26: 101-129.
177. Roses OE, Gambaro VE, Rofi R (1988a). La presencia de norhioscina y hioscina en flores de Brugmansia candida Pers. como posible caracteristica de su procedencia. Acta Farmacol. Bonaerense 7: 85- 90.
178. Roses OC, Villaamii EE, Garcia Fernandez JC, Miño JH (1988b). Accion farmacodinamica de las flores de la Brugmansia candida. Fitoterapia 59: 120-125.
179. Roses OE, Lopez CM, Garcia Fernandez JC (1987). Aislamiento e identificación de alcaloides del tropano en especies del género Brugmansia (Solanaceae). Acta Farmacologica Bonaerense 6: 167- 174.
180. Ruiz H (1998). Relación del viaje hecho a los reynos del Perú y Chile 1777-1788. Translated by Schultes ER, Nemry von Thenen de Jaramillo-Arango MJ as The Journals of Hippólito Ruiz, Portland, Timber Press.
181. Saeed SA, Bloch RM, Antonacci DJ (2007). Herbal and dietary supplements for treatment of anxiety disorders. Am. Family Phys., 76(4): 549-556.
182. Salah SM, Jäger AK (2005). Screening of traditionally used Lebanese herbs for neurological activities. J. Ethnopharmacol. 97(1): 145-149.
183. Santos MS, Ferreira F, Cunha AP, Carvalho AP, Macedo T (1994a). Aqueous extract of Valerian influences the transport of GABA in synaptosomes. Planta Med., 60: 278-279.
184. Santos MS, Ferreira F, Faro C, Pires E, Carvalho AP, Cunha AP, Macedo T (1994b). The amount of GABA present in aqueous extract of Valerian is sufficient to account for [3H]GABA release in synaptosomes. Planta Med., 60: 475-476.
185. Santos RG, Landeira-Fernandez J, Strassman RJ, Motta V, Cruz AP (2007). Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members. J. Ethnopharmacol., 112(3): 507-513.
186. Sarris J (2007). Herbal medicines in the treatment of psychiatric disorders, a systematic review. Phytother. Res., 21(8): 703-716.
187. Saxena G, Flora SJ (2006). Changes in brain biogenic amines and haem biosynthesis and their response to combined administration of succimers and Centella asiatica in lead poisoned rats. J. Pharm. Pharmacol. 58(4): 547-559.
188. Schultes RE (1955). A new narcotic genus from the Amazon slope in the Colombian Andes. Botanical Museum Leaflets, Harvard University, 17: 1-11.
189. Schultes RE (1972a). An overview of hallucinogens in western hemisphere. In, Furst, P. (Ed.), Flesh of the Gods, The Ritual Use of Hallucinogens. Praeger, New York, pp. 3-54.
190. Schultes RE (1972b). De Plantis toxicariis de Mundo Novo commentationes. XI. The ethnobotanical significance of additives to New World hallucinogens. Plant Sci. Bull., 18: 34-41.
191. Schultes RE (1972c). De Plantis Toxicariis e Mundo Novo Commentationes. X. New data on the Malpighiaceous narcotics of South America. Botanical Museum Leaflets, Harvard University, 23: 137-147.
192. Schultes RE (1979). Solanaceous hallucinogens and their role in the development of the new world cultures. In: Hawkes, JG, Lester RN, Shelding AD (eds) The Biology and Taxonomy of Solanaceae. London, Academic Press, pp. 137-160.
193. Schultes RE, Hofmann A (1992). Plants of the Gods, Their Sacred, Healing, and Hallucinogenic Powers. Healing Arts Press, Rochester.
194. Schultes RE, Raffauf R (1992). Vine of the Soul. Synergetic Press, Oracle, Arizona, 1992.
195. Sharon D, Bussmann RW (2006). Plantas Medicinales en la Obra del Obispo Don Baltasar Jaime Martínez Compañon (Siglo XVIII). In: Millones L, Kato T (eds) Desde el exterior, El Perú y sus estudios. Tercer Congreso Internacional de Peruanistas, Nagoya, UNMSM, FEFCS, Lima, pp. 147-165.
196. Sharon D (1972). The San Pedro cactus in Peruvian folk healing. In: Furst P (ed) Flesh of the Gods, The Ritual Use of Hallucinogens. Praeger, New York, pp. 114-135.
197. Sharon D (1978). Wizard of the Four Winds, A Shaman's Story. Free Press, New York.
198. Sharon D (1980). El Chamán de los Cuatro Vientos. Siglo veintiuno editores, México, D.F.
199. Sharon D (1994). Tuno y sus colegas, notas comparativas. In: Millones L, Lemlij M (eds) En el Nombre del Señor, Shamanes, demonios y curanderos del norte del Perú. Australis S.A., Lima, pp.128-147.
200. Sharon D (2000). Shamanismo y el Cacto Sagrado - Shamanism and the Sacred Cactus. San Diego Museum Papers p. 37.
201. Shulgin AT (1973). Mescaline, the chemistry and pharmacology of its analogs. Lloydia, 36: 45-58.
202. Shulgin AT (1979). Chemistry of phenethylamines related to mescaline. J. Psychedelic Drugs, 11: 41-52.
203. Singh D, Singh A (2005). The toxicity of four native Indian plants, effect on AChE and acid/alkaline phosphatase level in fish Channa marulius. Chemosphere. 60(1): 135-140.
204. Sonavane GS, Sarveiya VP, Kasture VS, Kasture SB (2002). Anxiogenic activity of Myristica fragrans seeds. Pharmacol. Biochem. Behavior., 71(1-2): 239-44.
205. Soulimani R, Fleurentin J, Mortier F, Misslin R, Derrieu G, Pelt JM (1991). Neurotropic action of the hydroalcoholic extract of Melissa officinalis in the mouse. Planta Med., 57: 105-109.
206. Sparre G, Harling B (eds) (1978-2009). Flora of Ecuador (various authors). Council for Nordic Publications in Botany.
207. Speroni E, Minghetti A (1988). Neuropharmacological activity of extracts from Passiflora incarnata. Planta Med., 54: 488-491.
208. Sufka KJ, Roach JT, Chambliss WG, Broom SL, Feltenstein MW, Wyandt CM, Zeng L (2001). Anxiolytic properties of botanical extracts in the chick social separation-stress procedure. Psychopharmacology (Berlin) 153(2): 219-224.
209. Szegedi A, Kohnen R, Dienel A, Kieser M (2005). Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's Wort), randomised controlled double blind non-inferiority trial versus paroxetine BMJ. 330(7490): 503.
210. Taddei I, Giacchetti D (1980). Fondamenti di Farmacognosia. Bologna, Editoriale Grasso.
211. Tafreshi AP, Ahmadi A, Ghaffarpur M, Mostafavi H, Rezaeizadeh H, Minaie B, Faghihzadeh S, Naseri M (2008). An Iranian herbal-marine medicine, MS14, ameliorates experimental allergic encephalomyelitis. Phytother. Res., 22(8): 1083-1086.
212. Tariq SH, Pulisetty S (2008). Pharmacotherapy for insomnia. Clin. Geriatric Med. 24(1): 93-105, vii.
213. Toriizuka K, Kamiki H, Ohmura NY, Fujii M, Hori Y, Fukumura M, Hirai Y, Isoda S, Nemoto Y, Ida Y (2005). Anxiolytic effect of Gardeniae Fructus-extract containing active ingredient from Kamishoyosan (KSS), a Japanese traditional Kampo medicine. Life Sci., 77(24): 3010-3020.
214. Torres CM (1995). Archaeological Evidence for the Antiquity of Psychoactive Plant Use in the Central Andes. Annuli dei Musei civici Roverero 11: 291-326.
215. Torres CM (1996). Status of Research on Psychoactive Snuff Powders, A Review of the Literature. In Jahrbuch für Erhnomedizin, Verlag für Wissenschaft und Bildung, Berlin, pp. 15-39.
216. Torres CM, Repke DB (1996). The Use of Anadenanrhera colubrina var. cebil by Wichi (Mataco) Shamans of the Chaco Central, Argentina. Jahrbuch fuer Ethnomedizin: 41-58.
217. Torres CM, Repke DB, Chan K, McKenna D, Llagostera A, Schultes RE (1991). Snuff powders from pre-Hispanic San Pedro de Atacama, chemical and contestual analysis. Curr. Anthropol., 32: 640-649.
218. Tortoriello J, Aguilar-Santamaría L (1996). Evaluation of the calciumantagonist, antidiarrhoeic and central nervous system activities of Baccharis serraefolia. J. Ethnopharmacol., 53(3): 157-163.
219. Ulloa Ulloa C, Jørgensen PM (1993). Arboles y arbustos de los Andes del Ecuador. AAU Reports 30: 1-263.
220. United Nations Conference on Trade and Development (UNCTD) (2000). Systems and National Experiences for Protecting Traditional Knowledge, Innovations and Practices. Background Note by the UNCTAD Secretariat. Geneva, United Nations Conference on Trade and Development, (document reference TD/B/COM.1/EM.13/2).
221. Valdizan H, Maldonado YA (1922). La medicina popular peruana. 3 tomos. Torres Aguirre, Lima.
222. Veerendra Kumar MH, Gupta YK (2003). Effect of Centella asiatica on cognition and oxidative stress in an intracerebroventricular streptozotocin model of Alzheimer's disease in rats. Clin. Exper. Pharmacol. Physiol., 30(5-6): 336-342.
223. Vermiglio F, Lo Presti VP, Moleti M, Sidoti M, Tortorella G, Scaffidi G, Castagna MG, Mattina F, Violi MA, Crisà A, Artemisia A, Trimarchi F (2004). Attention deficit and hyperactivity disorders in the offspring of mothers exposed to mild-moderate iodine deficiency, a possible novel iodine deficiency disorder in developed countries. J. Clin. Endocrinol. Metabol., 89(12): 6054-6060.
224. Vos JH, Geerts AA, Borgers JW, Mars MH, Muskens JA, van Wuijckhuise-Sjouke LA (2002). Senecio jacobaea, deceiving beauty. Senecio jacobaea poisoning. Tijdschrift Diergeneeskd, 127(24): 753- 756.
225. Wijeweera P, Arnason JT, Koszycki D, Merali Z (2006). Evaluation of anxiolytic properties of Gotukola (Centella asiatica) extracts and asiaticoside in rat behavioral models. Phytomedicine, 13(9-10): 668- 676.
226. Wilbert J (1972). Tobacco and shamanistic ecstasy among the Warrao Indians of Venezuela. In: Furst P (ed) Flesh of the Gods, The Ritual Use of Hallucinogens. Praeger, New York, pp. 53-83.
227. Wilbert J (1987). Tobacco and Shamanism in South America. Psychoactive Plants of the World, vol. 1. Yale University Press, New Haven and London.
228. World Health Organization (1998). Report, Technical Briefing on Traditional Medicine. Forty- ninth Regional Committee Meeting, Manila, Philippines, 18 September 1998. Manila, WHO Regional Office for the Western Pacific.
229. World Health Organization (1999a). Consultation Meeting on Traditional Medicine and Modern Medicine, Harmonizing the Two Approaches. Geneva, World Health Organization, (document reference (WP)TM/ICP/TM/001/RB/98- RS/99/GE/32(CHN)).
230. World Health Organization (1999b). Traditional, Complementary and Alternative Medicines and Therapies. Washington DC, WHO Regional Office for the Americas/Pan American Health Organization (Working group OPS/OMS).
231. World Health Organization (2002). WHO Traditional Medicine Strategy 2002-2005. World Health Organization, Geneva.
232. World Health Organization (2009a). World health fact sheet. http://www.int/mediacentre/factsheets/fs312/en/index.html. Accessed 05/15/20010.
233. World Health Organization (2009b). World health fact sheet. http://www.int/mediacentre/factsheets/fs297/en/index.html. Accessed 05/15/20010.
234. Wu JK, Huo JH, Du XW (2007). Pharmacological effects of volatile oil of Valeriana amurensis on CNS Zhong Yao Cai. 30(8): 977-980.
235. Yao M, Ritchie HE, Brown-Woodman PD (2007). A developmental toxicity-screening test of Valerian. J. Ethnopharm., 113(2): 204-209.
236. Yi LT, Li JM, Li YC, Pan Y, Xu Q, Kong LD (2008). Antidepressant-like behavioral and neurochemical effects of the citrus-associated chemical apigenin. Life Sci., 82(13-14): 741-751.
237. Zanoli P, Avallone R, Baraldi M (2000). Behavioral characterisation of the flavonoids apigenin and chrysin. Fitoterapia 71(1): 117-23.